CD31 (JC70) expression in plasma cells: an immunohistochemical analysis of reactive and neoplastic plasma cells

D Govender1, P Harilal, M Dada

  • 1Department of Anatomical Pathology, University of Natal Medical School, Durban, South Africa. govendh@med.und.ac.za

Insights

CD31 (JC70) is highly expressed on extramedullary reactive plasma cells and occasionally on plasmacytomas, but not on multiple myeloma cells. This finding aids in distinguishing reactive plasma cells from neoplastic plasma cells.

Area of Science:

  • Immunohistochemistry
  • Cell Adhesion Molecules

Background:

  • CD31 (JC70) is a cell adhesion molecule.
  • Understanding CD31 expression in plasma cells is crucial for diagnostics.

Purpose of the Study:

  • To investigate the immunohistochemical expression of CD31 (JC70) in normal and neoplastic plasma cells.

Main Methods:

  • Examined plasma cells from bone marrow and extramedullary biopsies.
  • Utilized anti-CD31 (JC70) staining with streptavidin-biotin detection.
  • Employed pressure cooking and microwave pretreatment for antigen retrieval.

Main Results:

  • Intense CD31 membrane staining observed in extramedullary reactive plasma cells.
  • Focal CD31 staining in bone marrow reactive plasma cells.
  • CD31 expression was absent in multiple myeloma cases.

Conclusions:

  • CD31 is strongly expressed in extramedullary reactive plasma cells.
  • CD31 expression is variable in plasmacytomas and reactive bone marrow plasma cells.
  • CD31 is a potential marker to differentiate reactive from neoplastic plasma cells.
Abstract